Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV.

Medicine & Life Sciences

• Anti-Retroviral Agents 81%
• HIV 40%
• Guidelines 37%
• Therapeutics 9%
• CD4 Lymphocyte Count 6%
• Virus Diseases 4%
• RNA 4%
• Viral Load 4%
• T-Lymphocytes 3%
• Drug Resistance 3%
• Risk Assessment 3%
• Pharmaceutical Preparations 3%
• United States Dept. of Health and Human Services 2%
• R Factors 2%
• Information Services 2%
• Patient Participation 2%
• Patient Education 2%
• Centers for Disease Control and Prevention (U.S.) 2%
• Reverse Transcriptase Polymerase Chain Reaction 2%
• Counseling 1%
• Acquired Immunodeficiency Syndrome 1%
• Disease Progression 1%
• History 1%
• Viruses 1%
• Clinical Trials 1%
• Quality of Life 1%
• Education 1%
• Morbidity 1%
• DNA 1%
• Mortality 1%

Social Sciences

• Clinical Practice 53%
• adolescent 34%
• drug 14%
• asymptomatic patients 14%
• suppression 7%
• human being 7%
• clinical management 5%
• adverse events 4%
• pregnant women 4%
• Clinical Trials 3%
• restoration 3%
• information service 3%
• morbidity 3%
• mortality 3%
• AIDS 3%
• health service 2%
• website 2%
• quality of life 2%
• counseling 2%
• education 2%
• history 1%
• management 1%

Chemical Compounds

• Antiretroviral 83%
• Drug 17%
• Resistance 15%
• Plasma 15%
• Henry Reaction 10%
• Ribonucleic Acid 10%
• Chain Reaction 8%
• Reduction 3%
• Acid 2%